Clinical Trials Directory

Trials / Completed

CompletedNCT01279252

CLL Empirical Antibiotic Regimen

A Phase II Trial of Broad Spectrum Antibiotic Therapy for Early Stage, Non-progressive Chronic Lymphocytic Leukaemia Without Adverse Prognostic Factors

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
71 (estimated)
Sponsor
King's College Hospital NHS Trust · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate whether patients with previously untreated, early stage CLL respond to empirical broad spectrum antibiotics and therefore test the hypothesis that occult bacterial infections are involved in the induction and maintenance of CLL.

Conditions

Interventions

TypeNameDescription
DRUGmetronidazole, clarithromycin, ciprofloxacin and lansoprazole

Timeline

Start date
2011-07-01
Primary completion
2015-01-01
Completion
2016-03-01
First posted
2011-01-19
Last updated
2019-01-25

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01279252. Inclusion in this directory is not an endorsement.